SLC34A2

Revision as of 14:39, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Solute carrier family 34 (sodium phosphate), member 2
Identifiers
Symbols SLC34A2 ; FLJ90534; NAPI-3B; NAPI-IIb; NPTIIb
External IDs Template:OMIM5 Template:MGI HomoloGene2297
RNA expression pattern
File:PBB GE SLC34A2 204124 at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Solute carrier family 34 (sodium phosphate), member 2, also known as SLC34A2, is a human gene.[1]


See also

References

  1. "Entrez Gene: SLC34A2 solute carrier family 34 (sodium phosphate), member 2".

Further reading

  • Feild JA, Zhang L, Brun KA; et al. (1999). "Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine". Biochem. Biophys. Res. Commun. 258 (3): 578–82. doi:10.1006/bbrc.1999.0666. PMID 10329428.
  • Xu H, Bai L, Collins JF, Ghishan FK (2000). "Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2)". Genomics. 62 (2): 281–4. doi:10.1006/geno.1999.6009. PMID 10610722.
  • Xu H, Collins JF, Bai L; et al. (2001). "Regulation of the human sodium-phosphate cotransporter NaP(i)-IIb gene promoter by epidermal growth factor". Am. J. Physiol., Cell Physiol. 280 (3): C628–36. PMID 11171583.
  • Segawa H, Kaneko I, Takahashi A; et al. (2002). "Growth-related renal type II Na/Pi cotransporter". J. Biol. Chem. 277 (22): 19665–72. doi:10.1074/jbc.M200943200. PMID 11880379.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Xu H, Uno JK, Inouye M; et al. (2005). "NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene". Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2): G175–81. doi:10.1152/ajpgi.00396.2004. PMID 15458926.
  • Otsuki T, Ota T, Nishikawa T; et al. (2007). "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries". DNA Res. 12 (2): 117–26. doi:10.1093/dnares/12.2.117. PMID 16303743.
  • Kimura K, Wakamatsu A, Suzuki Y; et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMID 16344560.
  • Corut A, Senyigit A, Ugur SA; et al. (2006). "Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis". Am. J. Hum. Genet. 79 (4): 650–6. doi:10.1086/508263. PMID 16960801.
  • Huqun , Izumi S, Miyazawa H; et al. (2007). "Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis". Am. J. Respir. Crit. Care Med. 175 (3): 263–8. doi:10.1164/rccm.200609-1274OC. PMID 17095743.

Template:WikiDoc Sources